Figure 7.

HLA-DSA status associates with worse allograft outcome after ABMRh diagnosis. (A–C) Kaplan–Meier curves of death-censored allograft survival based on ABMR histology with HLA-DSA, C4d positivity, or cellular rejection. C4d positivity is defined as a C4d score >0 by immunohistochemistry, or C4d >1 by immunofluorescence. Cellular rejection denotes borderline or TCMR. (D–F) Survival analysis based on average expression of selected gene sets and HLA-DSA. High molecular scores were defined as above the median value in the entire cohort.